The new new contracts, who’s behind them, and what they mean — delivered to your inbox every week. No credit card, unsubscribe anytime.
Weekly Digest
New new contracts, summarized for you
Straight to Inbox
No login, no app to check — it comes to you
Contract Trends
See who's moving and how much in your market
No credit card required Weekly contract digest
XOMA Royalty Corporation acquires 50 percent of Twist Bioscience’s existing royalty and milestone economics for $15 million
Oct 22, 2024•over 1 year ago
Contract Type
agreement
EmeryvilleBiotechnologyHealth Care
Description
XOMA Royalty Corporation has entered into a $15 million royalty monetization arrangement with Twist Bioscience Corporation to acquire a 50 percent economic interest in all future milestones and royalties associated with the 60-plus partnered early-stage programs across 30 partners enabled by Twist Bioscience’s Biopharma Solutions business unit.
Company Information
Company
XOMA Royalty Corporation
Location
Emeryville, California, United States
About
XOMA Royalty Corporation is a biotechnology royalty aggregator playing a distinctive role in helping biotech companies achieve their goal of improving human health. XOMA Royalty acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceutical or biotechnology companies. The company has an extensive and growing portfolio of assets.
EmeryvilleBiotechnologyHealth Care